“Pseudo”-Secondary Treatment Failure Explained via Disease Progression and Effective Botulinum Toxin Therapy: A Pilot Simulation Study

Background: The objective of this study was to provide evidence from a simple simulation. In patients with focal dystonia, an initial good response to botulinum neurotoxin (BoNT) injections followed by a secondary worsening does not necessarily arise from an antibody-induced secondary treatment fail...

Full description

Bibliographic Details
Main Authors: Harald Hefter, Dietmar Rosenthal, Sara Samadzadeh
Format: Article
Language:English
Published: MDPI AG 2023-10-01
Series:Toxins
Subjects:
Online Access:https://www.mdpi.com/2072-6651/15/10/618